Related Experiment Video
Updated: Jul 6, 2026
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Multiple system atrophy: pathophysiology, treatment and nursing care.
1Queen Elizabeth Hospital, King's Lynn. joannehardy07@aol.com
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|March 13, 2008
Summary
Multiple system atrophy (MSA) is a degenerative neurological disorder. Nurses play a vital role in managing MSA symptoms and supporting patients and families for improved quality of life.
Area of Science:
- Neurology
- Gerontology
- Nursing Care
Background:
- Multiple system atrophy (MSA) is a rare, progressive neurodegenerative disorder.
- Characterized by parkinsonism, ataxia, and autonomic dysfunction.
- Requires a multidisciplinary approach for comprehensive patient management.
Observation:
- The article reviews the symptoms and management strategies for MSA.
- Highlights the essential role of nursing within a multidisciplinary team.
- Emphasizes holistic care to enhance patient independence and quality of life.
Findings:
- Nurses provide crucial physical and emotional support to patients with MSA and their families.
- Proactive nursing interventions can mitigate the impact of progressive disability.
- Effective management focuses on maintaining independence and quality of life despite disease progression.
Implications:
- Enhanced understanding of nursing's role in managing complex neurological conditions.
- Importance of integrated care models for progressive, life-limiting diseases.
- Nurses are key in supporting patients and families through the challenges of MSA.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...